Immunosuppressants: A Drug Therapy For Psoriasis Management In Geriatrics
Immunosuppressive medications are frequently utilized to manage autoimmune skin disorders, stemming from an overactive immune system. Nonetheless, their prolonged usage in elders can lead to serious side effects. Consequently, continuous monitoring is essential throughout treatment to promptly identify adverse effects. One of the most significant risks is an increased susceptibility to infections. Since immunosuppressants lower the body's natural defenses, patients become more vulnerable to bacterial, viral, and fungal infections. This risk is compounded in older adults, whose immune systems are already less robust. Another major concern is the heightened risk of cancers. The suppression of the immune system can reduce the body's ability to detect and destroy cancerous cells, leading to a higher incidence of malignancies. Additionally, long-term immunosuppressive therapy can cause metabolic issues, including diabetes, hypertension, and osteoporosis, further complicating the health status of elderly patients. Regular check-ups and tests are necessary to identify and manage any adverse effects promptly. This proactive approach helps to mitigate risks, ensuring that the benefits of immunosuppressive treatment outweigh the drawbacks, particularly in vulnerable elderly populations.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-10-24
- DOI
- https://doi.org/10.5281/zenodo.13987697
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00